| Enzalutamide Accord 40 mg soft capsules PA2315/257/001 |
Enzalutamide |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Enzalutamide Clonmel 160 mg film-coated tablets PA0126/411/001 |
Enzalutamide |
Clonmel Healthcare Ltd |
Not marketed |
| Enzalutamide Clonmel 40 mg film-coated tablets PA0126/389/001 |
Enzalutamide |
Clonmel Healthcare Ltd |
Not marketed |
| Enzalutamide Clonmel 80 mg film-coated tablets PA0126/389/002 |
Enzalutamide |
Clonmel Healthcare Ltd |
Not marketed |
| Enzalutamide Rowex 40 mg film-coated tablets PA0711/332/001 |
Enzalutamide |
Rowex Limited, |
Not marketed |
| Enzalutamide Rowex 40 mg film-coated tablets PA0711/334/001 |
Enzalutamide |
Rowex Limited, |
Not marketed |
| Enzalutamide Rowex 80 mg film-coated tablets PA0711/332/002 |
Enzalutamide |
Rowex Limited, |
Not marketed |
| Enzalutamide Rowex 80 mg film-coated tablets PA0711/334/002 |
Enzalutamide |
Rowex Limited, |
Not marketed |
| Enzalutamide Teva 40 mg film-coated tablets PA22579/005/001 |
Enzalutamide |
TEVA GmbH |
Not marketed |
| Enzalutamide Teva 80 mg film-coated tablets PA22579/005/002 |
Enzalutamide |
TEVA GmbH |
Not marketed |
| Enzalutamide Viatris 40 mg Film-coated tablet EU/1/24/1842/001-003 |
Enzalutamide |
Viatris Limited |
— |
| Enzalutamide Viatris 80 mg Film-coated tablet EU/1/24/1842/004-006 |
Enzalutamide |
Viatris Limited |
— |
| Enzalutamide Zentiva 40 mg film-coated tablets PA1701/018/001 |
Enzalutamide |
Zentiva k.s. |
Not marketed |
| Enzalutamide Zentiva 80 mg film-coated tablets PA1701/018/002 |
Enzalutamide |
Zentiva k.s. |
Not marketed |
| Epaclob 1 mg/ml Oral Suspension PA0549/026/001 |
Clobazam |
Ethypharm |
Marketed |
| Epaclob 2 mg/ml Oral Suspension PA0549/026/002 |
Clobazam |
Ethypharm |
Marketed |
| Epanutin 100 mg Hard Capsules PA23355/050/003 |
PHENYTOIN SODIUM |
Viatris Healthcare Limited |
Marketed |
| Epanutin 100 mg Hard Capsules PPA0465/244/001 |
PHENYTOIN SODIUM |
PCO Manufacturing Ltd. |
— |
| Epanutin 25 mg Hard Capsules PA23355/050/001 |
PHENYTOIN SODIUM |
Viatris Healthcare Limited |
Marketed |
| Epanutin 30 mg/5ml Oral Suspension PA23355/050/007 |
Phenytoin |
Viatris Healthcare Limited |
Marketed |
| Epanutin 300 mg Hard Capsules PA23355/050/004 |
PHENYTOIN SODIUM |
Viatris Healthcare Limited |
Marketed |
| Epanutin 50 mg Hard Capsules PA23355/050/002 |
PHENYTOIN SODIUM |
Viatris Healthcare Limited |
Marketed |
| Epanutin Infatabs 50mg Chewable Tablets PA23355/050/005 |
Phenytoin |
Viatris Healthcare Limited |
Marketed |
| Epanutin Ready Mixed Parenteral 250 mg/5 ml Solution for Injection or Infusion PA23355/050/006 |
PHENYTOIN SODIUM |
Viatris Healthcare Limited |
Marketed |
| Epclusa 150 mg/37.5 mg coated granules in sachet EU/1/16/1116/003 |
Sofosbuvir, Velpatasvir |
Gilead Sciences Ireland UC |
— |
| Epclusa 200 mg/50 mg coated granules in sachet EU/1/16/1116/004 |
Sofosbuvir, Velpatasvir |
Gilead Sciences Ireland UC |
— |
| Epclusa 200 mg/50 mg film-coated tablets EU/1/16/1116/002 |
Sofosbuvir |
Gilead Sciences Ireland UC |
— |
| Epclusa 400 mg/100 mg film-coated tablets EU/1/16/1116/001 |
Sofosbuvir, Velpatasvir |
Gilead Sciences Ireland UC |
— |
| Ephedrine Hydrochloride 3 mg/ml solution for injection PA1968/011/002 |
Ephedrine hydrochloride |
Laboratoire Aguettant |
Not marketed |
| Ephedrine Hydrochloride 3 mg/ml solution for injection in pre-filled syringe PA1968/011/001 |
Ephedrine hydrochloride |
Laboratoire Aguettant |
Marketed |
| Ephedrine Hydrochloride 30 mg/ ml solution for injection PA1968/011/003 |
Ephedrine hydrochloride |
Laboratoire Aguettant |
Not marketed |
| Ephedrine Hydrochloride 30mg in 1ml Solution for Injection PA0549/027/001 |
Ephedrine hydrochloride |
Ethypharm |
Marketed |
| Ephedrine Kabi 10 mg/mL solution for injection PA2059/086/002 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ephedrine Kabi 3 mg/mL solution for injection PA2059/086/001 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ephedrine Kabi 30 mg/mL solution for injection PA2059/086/003 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Epiduo 0.1%/2.5% gel PA22743/007/001 |
Adapalene, Benzoyl Peroxide |
Galderma International |
Marketed |
| Epiduo 0.1%/2.5% gel PPA0465/519/001 |
Adapalene, Benzoyl Peroxide |
PCO Manufacturing Ltd. |
— |
| Epiduo 0.3 %/2.5 % gel PA22743/007/002 |
Adapalene, Anhydrous Benzoyl Peroxide |
Galderma International |
Not marketed |
| Epidyolex 100 mg/ml oral solution EU/1/19/1389/001 |
CANNABIDIOL |
Jazz Pharmaceuticals Ireland Limited |
— |
| Epilim 100 mg Crushable Tablets PA0540/150/001 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chrono 200mg Prolonged Release Tablets PA0540/150/010 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chrono 300mg Prolonged Release Tablets PA0540/150/011 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chrono 500mg Prolonged Release Tablets PA0540/150/012 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chronosphere 100mg prolonged-release granules PA0540/150/005 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chronosphere 250mg prolonged-release granules PA0540/150/006 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chronosphere 500mg prolonged-release granules PA0540/150/007 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Enteric 200 mg gastro-resistant coated tablets PA0540/150/002 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Enteric 500mg Gastro-resistant Coated Tablets PA0540/150/003 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Intravenous 400mg powder and solvent for solution for injection or infusion PA0540/150/013 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Liquid 200 mg/5ml Oral Solution PA0540/150/014 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |